Compounds > ouabain

ouabain and quinazolines

ouabain has been researched along with quinazolines in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19905 (71.43)18.7374
1990's1 (14.29)18.2507
2000's0 (0.00)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ebbert, M; Janssens, WJ; Leidig, A; Meuter, C; Peters, T; Wilffert, B; Wilhelm, D1
Chiba, S; Katsuyama, Y; Tada, A; Tsukada, M; Zenda, H1
Fairfax, CA; Tanz, RD1
Byrne, JE; Gomoll, AW; McKinney, GR1
Belair, E; Borrelli, A; Kaiser, F; Yelnosky, J1
Grant, SJ; Jablons, D; Maas, JW; Swann, AC1
Blanco, G; Jansson, K; Nguyen, AN; Reif, GA; Sánchez, G; Sharma, M; Wallace, DP1

Other Studies

7 other study(ies) available for ouabain and quinazolines

ArticleYear
In vitro pharmacology of R 80122, a novel phosphodiesterase inhibitor.
    Journal of cardiovascular pharmacology, 1992, Volume: 20, Issue:5

    Topics: Action Potentials; Animals; Benzimidazoles; Carbachol; Female; Guinea Pigs; Heart Rate; Imidazoles; In Vitro Techniques; Isoproterenol; Male; Milrinone; Myocardial Contraction; Norepinephrine; Ouabain; Oxindoles; Papillary Muscles; Phosphodiesterase Inhibitors; Pyridones; Quinazolines; Stimulation, Chemical; Vasodilator Agents

1992
Vasoconstrictor effects of endogenous digitalis-like factors extracted from urine of hypertensive patients.
    Heart and vessels, 1987, Volume: 3, Issue:3

    Topics: Animals; Arteries; Blood Proteins; Cardenolides; Digoxin; Dogs; Ear, External; Epinephrine; Humans; Hypertension; In Vitro Techniques; Mesenteric Arteries; Ouabain; Phentolamine; Potassium Chloride; Quinazolines; Saponins; Vasoconstrictor Agents; Verapamil

1987
Insurmountable antagonism of ouabain-induced coronary constriction by prazosin.
    European journal of pharmacology, 1985, May-28, Volume: 112, Issue:1

    Topics: Animals; Coronary Vessels; In Vitro Techniques; Ouabain; Prazosin; Quinazolines; Swine; Vasoconstriction; Verapamil

1985
Interactions of quazodine with cardiotoxic doses of ouabain in the anesthetized dog.
    Archives internationales de pharmacodynamie et de therapie, 1974, Volume: 207, Issue:1

    Topics: Adrenergic beta-Agonists; Aminophylline; Animals; Arrhythmias, Cardiac; Blood Pressure; Dogs; Drug Interactions; Electrocardiography; Heart Rate; Methyl Ethers; Ouabain; Quinazolines

1974
Interaction studies with metolazone, ouabain and lidocaine.
    Archives internationales de pharmacodynamie et de therapie, 1972, Volume: 197, Issue:1

    Topics: Animals; Blood Pressure; Diuretics; Dogs; Drug Interactions; Femoral Artery; Heart Rate; Ketones; Lidocaine; Ouabain; Potassium; Quinazolines; Sulfonamides; Tachycardia; Ventricular Function

1972
Increased ouabain binding after repeated noradrenergic stimulation.
    Brain research, 1981, Jun-01, Volume: 213, Issue:2

    Topics: 4-Nitrophenylphosphatase; Animals; Cell Membrane; Cerebral Cortex; Male; Ouabain; Phosphoric Monoester Hydrolases; Piperidines; Piperoxan; Prazosin; Protein Binding; Quinazolines; Rats

1981
Ouabain activates the Na-K-ATPase signalosome to induce autosomal dominant polycystic kidney disease cell proliferation.
    American journal of physiology. Renal physiology, 2011, Volume: 301, Issue:4

    Topics: beta-Cyclodextrins; Caveolin 1; Cell Proliferation; Cells, Cultured; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Enzyme Inhibitors; ErbB Receptors; Humans; MAP Kinase Kinase Kinases; Ouabain; Phosphorylation; Polycystic Kidney, Autosomal Dominant; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-fyn; Pyrimidines; Quinazolines; Signal Transduction; Sodium-Potassium-Exchanging ATPase; src-Family Kinases; Tyrphostins

2011